Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002

NCT01338935 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

136

Enrollment

OTHER

Sponsor class

Stopped Pharmacokinetic stopping criteria for the study were met.

Conditions

Healthy

Interventions

DRUG: CW 002
DRUG: CW 002
DRUG: CW 002

Sponsor

Weill Medical College of Cornell University